Search

everythinglearnresearchcommunity

for

Search:↓

Men with untreated male pattern hair loss continue to lose hair over a 5-year period.

Taking finasteride can partially improve oxygen levels in hospitalized male patients over 50 with COVID-19 pneumonia, but it doesn't affect other outcomes like death rate or hospital stay length.

Researchers developed a scaffold that releases a healing drug over time, improving wound healing and skin regeneration.

Doublebase gel hydrates skin better and is preferred by most users over Aqueous cream.

Children with autoimmune gastritis showed improved intestinal health over time and should be checked for other autoimmune conditions.

Muskoxen's qiviut cortisol levels indicate their stress hormone activity over the hair growth period.

Long-COVID symptoms can last more than a year and change over time.

Dutasteride effectively and safely treats male hair loss for over a year.

Dermatologic surgery has greatly improved with new techniques over the years.

The girl with long eyelashes and hair loss was monitored over time to understand and manage her condition better.

Fiber implants effectively treat permanent hair loss with over 85% success and minimal complications.

Greasy hair spreads sebum twice as much as nongreasy hair over time.

The congress highlighted concerns about the effectiveness of over-the-counter nail treatments, the link between hair loss and daily care products, and the safety of skin treatments during COVID-19.

Nanostructured lipid carriers can effectively repair hair split-ends for over 3 days.

Pharmacists play a key role in helping patients use over-the-counter products correctly, including those for hair regrowth and smoking cessation.

Irradiating the whole central nervous system can lead to over 50% of patients with cerebellar medulloblastoma surviving three years.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

New punch technologies have improved hair transplant results over time.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Hair restoration surgery has a growing risk of hair loss over time.

Hair transplant techniques have improved and become less invasive over time, but there are concerns about unregulated centers. The market is growing, with potential for more growth in India due to increasing hair loss cases. New technologies like robotic transplants are promising for the future. Surgeons are encouraged to prioritize patient safety and understand the science behind their techniques.

Hair loss after weight loss surgery can improve over time.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Exosomes show promise for tissue repair and regeneration with advantages over traditional cell therapies.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

Oxidized hair can naturally regain strength and stability over six months.